T
TBIO

TCWP’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

TCWP’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed – – 1859
2022
Q1 		$0 Buy
+1
New +$152 ﹤0.01% 1945

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCWP's TBIO Position: Q2 2022 in Review

TCWP sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q2 2022, closing a stake of 1 share.

TCWP first reported a position in TBIO in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 37 funds tracked by Wall St. Rank hold TBIO as of Q2 2022.

  • TCWP reported no remaining Telesis Bio, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 1 Telesis Bio, Inc. Common Stock share in Q2 2022.
  • TCWP first reported a position in Telesis Bio, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • TCWP's Telesis Bio, Inc. Common Stock position peaked at $0 in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.